Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology 
SeaSpine to Report First Quarter 2021 Financial Results on May 3, 2021
CARLSBAD, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on...
TRIO Completes Enrollment of Phase III NATALEE Breast Cancer Clinical Trial
Over 5000 Patients Enrolled in 20 countriesEDMONTON, Alberta, April 21, 2021 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO) today...
Treatment.com – Building the Smartest Artificial Intelligence (AI) System for Healthcare
VANCOUVER, British Columbia, April 21, 2021 (GLOBE NEWSWIRE) -- “AI has no greater purpose than improving the health of everyone,”...
New Leaf Canada Gets Health Canada Approval for Psirenity to Begin Building Psilocybin Research Facility in Norfolk County
TORONTO, April 21, 2021 (GLOBE NEWSWIRE) -- New Leaf Canada Inc. today announced it has received approval from Health Canada...
Enzo’s Universal AMPICOLLECT™ Used on GENFLEX® Molecular Platform Cleared for Distribution by FDA Under Emergency Use Authorization
Company’s specimen collection kit now available for use in COVID-19 testing in the U.S. Sample collection kit can be used...
Adverum Mails Letter to Stockholders Highlighting World-Class Board of Directors Overseeing Successful ADVM-022 Commercial Launch
Adverum Slate Background Adverum Slate Background Adverum Board Matrix Adverum Board Matrix Sonic’s Nominees Lack Experience and Qualifications to Advance...
Ayala Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of AL102 in Combination with BCMA Targeting Agent, WVT078, in Patients with relapsed/refractory Multiple Myeloma
REHOVOT, Israel and WILMINGTON, Del., April 21, 2021 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company...
BriaCell CEO Gives Corporate Overview, Plans for Future in Audio Interview with SmallCapVoice.com
AUSTIN, Texas, April 21, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Bill...
Vaccinex Announces Publication of Results from CLASSICAL-Lung Phase 1b/2 Clinical Trial in Non-Small Cell Lung Cancer in the Peer-Reviewed Journal Clinical Cancer Research
CLASSICAL-Lung study evaluated pepinemab in combination with the checkpoint inhibitor BAVENCIO® for the treatment of non-small cell lung cancerROCHESTER, N.Y.,...
Brii Biosciences, Vir Biotechnology and VBI Vaccines Announce Initiation of Phase 2 Clinical Trial of BRII-835 (VIR-2218) in Combination with BRII-179 (VBI-2601) for the Treatment of Hepatitis B
New combination trial of an RNA-targeted therapeutic candidate and an HBV immunotherapeutic candidate aimed at delivering a functional cure for...
Pharvaris Announces FDA Acceptance of IND Application for Prophylactic Treatment of HAE Using PHVS416
Company on track to initiate prophylactic study of PHVS416ZUG, Switzerland, April 21, 2021 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a...
Humacyte Announces Positive Long-Term Follow-Up Data from Phase 2 Vascular Access Trial
Five-year outcomes demonstrate HAV retained durability and structural integrity, potentially offering a safe and viable option for long-term hemodialysisLong-term explant...
Mustang Bio to Participate in Chardan’s 5th Annual Genetic Medicines Manufacturing Summit
WORCESTER, Mass., April 21, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on...
Replimune Appoints Genentech Global Oncology Franchise Head Sushil Patel, Ph.D. as Chief Commercial Officer
WOBURN, Mass., April 21, 2021 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies...
Lowell Farms to Announce First Quarter Financial Results
Cannabis industry leader to hold conference call on May 5SALINAS, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- Lowell Farms (CSE:LOWL;...
Antios Therapeutics Doses First Patients in SAVE 1, a Phase 2a Study of ATI-2173 in Patients with Chronic Hepatitis B Virus (HBV)
SAVE 1 to evaluate ATI-2173 in combination with tenofovir (TDF) vs. TDF plus placebo SAVE 1 to include cohort of...
NexImmune Appoints Chad Rubin as Senior Vice President, Corporate Affairs
Mr. Rubin most recently served as Managing Director, Co-Head Life Sciences for Solebury TroutGAITHERSBURG, Md., April 21, 2021 (GLOBE NEWSWIRE)...
Virtual End-to-End Care in Workers’ Compensation to be Presented at RIMS
CorVel Session Looks at How the Pandemic Pushed Transformation of Care, Next StepsIRVINE, Calif., April 21, 2021 (GLOBE NEWSWIRE) --...
Cyclerion Therapeutics to Participate in the B. Riley Neuroscience Investor Conference
CAMBRIDGE, Mass., April 21, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission...
Top Scarless Robotic Thyroid Surgery Center Led By Surgeon Dr Hyun Suh Opened
North America’s leading Thyroid Surgery Center has established the Suh Scarless Thyroid Surgery Center in Tampa Florida, to provide the...